| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| lirilumab | ras-like protein kir | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Leukemia Myelocytic Acute[MeSHID:D015470] Chronic Lymphocytic Leukemia[MeSHID:D015451] Malignant Neoplasms[MeSHID:D009369] |
15.91 | phase 2 | unknown |
| click here to return to the previous page | ||||||||